Tumor localized agonistic anti-CD40 therapy and beyond
Expert Opin Biol Ther
.
2020 Mar;20(3):215-217.
doi: 10.1080/14712598.2020.1713084.
Epub 2020 Jan 10.
Authors
Mohamed Eltahir
1
,
Helena Persson
2
3
,
Sara Mangsbo
1
Affiliations
1
Department of Pharmaceutical Biosciences, Science for Life laboratory, Uppsala University, Sweden.
2
Drug Discovery and Development, Science for Life Laboratory, Stockholm, Sweden.
3
School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institute of Technology (KTH), Stockholm, Sweden.
PMID:
31920122
DOI:
10.1080/14712598.2020.1713084
No abstract available
Keywords:
CD40; Cancer; Immunotherapy; Monoclonal.
Publication types
Editorial
Research Support, Non-U.S. Gov't